NO872675L - Middel for hemning av avstoetning av transplanterte organer - Google Patents

Middel for hemning av avstoetning av transplanterte organer

Info

Publication number
NO872675L
NO872675L NO872675A NO872675A NO872675L NO 872675 L NO872675 L NO 872675L NO 872675 A NO872675 A NO 872675A NO 872675 A NO872675 A NO 872675A NO 872675 L NO872675 L NO 872675L
Authority
NO
Norway
Prior art keywords
heparin
disposal
inhibiting
humans
transplanted organs
Prior art date
Application number
NO872675A
Other languages
English (en)
Other versions
NO872675D0 (no
Inventor
Irun Cohen
Israel Vlodavsky
Amiram Eldor
Yaakov Naparstek
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of NO872675D0 publication Critical patent/NO872675D0/no
Publication of NO872675L publication Critical patent/NO872675L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Transplantation (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Soil Working Implements (AREA)
  • Paper (AREA)
  • Fertilizers (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO872675A 1986-06-26 1987-06-25 Middel for hemning av avstoetning av transplanterte organer NO872675L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL79254A IL79254A0 (en) 1986-06-26 1986-06-26 Compositions for preventing graft rejection

Publications (2)

Publication Number Publication Date
NO872675D0 NO872675D0 (no) 1987-06-25
NO872675L true NO872675L (no) 1987-12-28

Family

ID=11056896

Family Applications (1)

Application Number Title Priority Date Filing Date
NO872675A NO872675L (no) 1986-06-26 1987-06-25 Middel for hemning av avstoetning av transplanterte organer

Country Status (10)

Country Link
EP (1) EP0251134B1 (no)
JP (1) JP2527749B2 (no)
AT (1) ATE82502T1 (no)
AU (1) AU608228B2 (no)
DE (1) DE3782686T2 (no)
DK (1) DK169422B1 (no)
ES (1) ES2052514T3 (no)
GR (1) GR3006814T3 (no)
IL (1) IL79254A0 (no)
NO (1) NO872675L (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5541166A (en) * 1987-01-23 1996-07-30 The Australian National University Sulphated polysaccharides having anti-metastatic and/or anti-inflammatory activity
IL85145A (en) * 1987-01-23 1994-08-26 Univ Australian Anti-metastatic pharmacological or veterinary preparations containing modified herpin with reduced anticoagulant activity
GB8808810D0 (en) * 1988-04-14 1988-05-18 Biopharm Clinical Research Ltd Heparin-containing formulations
IL86753A0 (en) * 1988-06-15 1988-11-30 Hadassah Med Org Pharmaceutical compositions for treatment of lupus
DE3821271A1 (de) * 1988-06-23 1989-12-28 Solco Basel Ag Derivatisiertes heparin, verfahren zu dessen herstellung und arzneimittel, welches dieses enthaelt
IL88554A0 (en) * 1988-12-01 1989-07-31 Hadassah Med Org Compositions containing a compound binding to a heparin receptor
US5158940A (en) * 1990-02-14 1992-10-27 The United States Government As Represented By The Secretary, Dhhs Use of suramin to treat rheumatologic diseases
CA2296409C (en) 1997-07-14 2010-05-18 Meiji Milk Products Co., Ltd. Agents comprising midkine or its inhibitor as active ingredient
WO2001057184A2 (en) * 2000-02-01 2001-08-09 Vanderbilt University Use of platelet activity modulators for inhibiting complement activation
CN1197587C (zh) * 2000-06-09 2005-04-20 中国科学院上海细胞生物学研究所 N－位脱硫酸肝素在预防和治疗炎症中的应用
EP2343077B1 (en) 2001-09-12 2013-07-17 SIGMA-TAU Research Switzerland S.A. Derivatives of totally N-desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect
CA2567495C (en) 2004-05-27 2014-02-18 Avigen, Inc. Methods for treating bleeding disorders using sulfated polysaccharides
CA2731304C (en) 2008-08-22 2017-06-06 Baxter Healthcare S.A. Methods for treating bleeding disorders using non-anticoagulant sulfated polysaccharides
EP2523553B1 (en) 2010-01-14 2020-04-08 Baxalta GmbH Methods and compositions for treating bleeding disorders
CN103841979B (zh) 2011-07-19 2019-01-11 百深有限责任公司 作为改善非抗凝血的硫酸多糖的口服制剂的添加剂的吸收促进剂
US9417251B2 (en) 2012-08-14 2016-08-16 Baxalta GmbH Methods and systems for screening compositions comprising non-anticoagulant sulfated polysaccharides
EP2968400B1 (en) 2013-03-12 2019-05-08 Baxalta GmbH Resorption enhancers as additives to improve the oral formulation of low molecular weight heparins
SE538503C2 (en) 2014-11-11 2016-08-16 Tx Medic Ab New dextran sulfate
JP6887628B2 (ja) * 2015-06-11 2021-06-16 ユニフェルシテイト マーストリヒトＵｎｉｖｅｒｓｉｔｅｉｔ Ｍａａｓｔｒｉｃｈｔ 被移植体における移植不全を防ぐ方法

Also Published As

Publication number Publication date
ES2052514T3 (es) 1994-07-16
DE3782686D1 (de) 1992-12-24
EP0251134B1 (en) 1992-11-19
EP0251134A3 (en) 1989-05-03
AU7470687A (en) 1988-01-07
EP0251134A2 (en) 1988-01-07
DK331287D0 (da) 1987-06-26
JPS6388127A (ja) 1988-04-19
ATE82502T1 (de) 1992-12-15
DK169422B1 (da) 1994-10-31
JP2527749B2 (ja) 1996-08-28
AU608228B2 (en) 1991-03-28
DK331287A (da) 1987-12-27
DE3782686T2 (de) 1993-06-09
IL79254A0 (en) 1986-09-30
NO872675D0 (no) 1987-06-25
GR3006814T3 (no) 1993-06-30

Similar Documents

Publication Publication Date Title
NO872675L (no) Middel for hemning av avstoetning av transplanterte organer
DE3587266D1 (de) Verfahren und system zur entfernung von immunosuppressiven bestandteilen aus saeugetierblut.
ATE190496T1 (de) Behandlung von autoimmunkrankheiten durch verabreichung von autoantigenen in form von aerosol
MX9101869A (es) Ciclosporinas, composicion farmaceutica que las contiene y procedimiento para la produccion de las mismas
ES2137225T3 (es) Eliminacion de anticuerpos de composiciones de derivados sanguineos reteniendo los factores de coagulacion.
ES2032316T3 (es) Procedimiento para la esterilizacion de plasma o fracciones de plasma.
ES2082850T3 (es) Inmunoglobulinas preparadas geneticamente.
ATE135215T1 (de) Verwendung von rapamycin, dessen derivaten und prodrugs zur herstellung eines arzneimittels zur hemmung der transplantatabstossung bei säugetieren
DK602387D0 (da) Fremgangsmaade til fremstilling af glucosaminer med lav molekylvaegt og anvendelse af saadanne glucosaminer
ATE10340T1 (de) Stabilisierung der aktivitaet des faktors viii im blutplasma.
DE69435303D1 (de) Er behandlung von krankheiten bei denen eine cytok
DE69023957D1 (de) Sulfatierte Polysaccharide, Antikoagulierungs- und Antikomplementärmittel, hergestellt aus Fukanen aus braunen Algen, und Verfahren zu deren Herstellung.
ATE190623T1 (de) Verwendung von steroiden zur inhibierung von angiogenesis
EP0011651A4 (en) Pharmaceutical preparation containing 3-oxo-2,3-dihydro (1) -benzothiophene-2-spirocyclopropane and this compound for use in the prophylaxis or treatment of caridovascular disorders.
DE3584560D1 (de) Arzneimittelzusammensetzung geeignet zur behandlung oder prophylaxe von herzstoerungen.
DE3854121D1 (de) Arzneimittelzusammensetzungen zur behandlung von psoriasis.
ATE81467T1 (de) Immunosuppression bei der auf immunotoxin basierten behandlung von menschen.
NO832092L (no) Fremgangsmaate ved fremstilling av et heparinfragment
EP0058397A3 (en) Anticoagulant and the use thereof
ATE113591T1 (de) 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol- - one und ihre verwendung als antikonvulsiva.
DE3751362D1 (de) 5-Aryl-3H-1,2,4-triazol-3-one und ihre Verwendung als Antikonvulsiva.
DE69919578D1 (de) VERWENDUNG von NIEDERMOLEKULAREM HEPARIN zur Behandlung und/oder Prophylaxe motoneuronaler Krankheiten
BR8400127A (pt) Composicao para o combate de crescimento indesejado de plantas,processo para a obtencao de 3,4-di-(metilamino)-6-terc.-butil-4,5-dihidro-1,2,4-triazin-5-ona,processo para a obtencao de uma composicao utilizacao e processo para o combate de ervas daninhas
DE69022027D1 (de) 2-Alkyl-3-benzoylbenzofurane zur Behandlung von Herzarrhythmia.
De Costa Severe poisoning by cholinesterase inhibition in Portugal.